Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q4 2025 value amounting to -$20000.0.

  • Enanta Pharmaceuticals' Amortizatization of Intangibles rose 9683.54% to -$20000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $109000.0, marking a year-over-year decrease of 8602.56%. This contributed to the annual value of -$503000.0 for FY2025, which is 14420.04% down from last year.
  • Enanta Pharmaceuticals' Amortizatization of Intangibles amounted to -$20000.0 in Q4 2025, which was up 9683.54% from $958000.0 recorded in Q3 2025.
  • In the past 5 years, Enanta Pharmaceuticals' Amortizatization of Intangibles registered a high of $1.4 million during Q2 2023, and its lowest value of -$816000.0 during Q1 2025.
  • Its 5-year average for Amortizatization of Intangibles is $30750.0, with a median of -$39000.0 in 2022.
  • As far as peak fluctuations go, Enanta Pharmaceuticals' Amortizatization of Intangibles skyrocketed by 177812.5% in 2024, and later crashed by 316400.0% in 2025.
  • Over the past 5 years, Enanta Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at -$546000.0 in 2021, then surged by 162.09% to $339000.0 in 2022, then plummeted by 180.83% to -$274000.0 in 2023, then plummeted by 130.66% to -$632000.0 in 2024, then surged by 96.84% to -$20000.0 in 2025.
  • Its last three reported values are -$20000.0 in Q4 2025, $958000.0 for Q3 2025, and -$13000.0 during Q2 2025.